BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 12798907)

  • 1. Vascular endothelial growth factor--mediator of OHSS?
    McDonough PG
    Fertil Steril; 2003 Jun; 79(6):1466-7. PubMed ID: 12798907
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor-mediator of PHSS?
    Kol S
    Fertil Steril; 2003 Jun; 79(6):1466; author reply 1466. PubMed ID: 12798905
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vascular endothelial growth factor receptor--structure and function].
    Liu L; Hu BC; Zhang YJ
    Sheng Li Ke Xue Jin Zhan; 2000 Jul; 31(3):269-72. PubMed ID: 12545721
    [No Abstract]   [Full Text] [Related]  

  • 5. Vascular endothelial growth factor and its receptors in multiple myeloma.
    Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
    Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor.
    Pellicer A; Albert C; Mercader A; Bonilla-Musoles F; Remohí J; Simón C
    Fertil Steril; 1999 Mar; 71(3):482-9. PubMed ID: 10065786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The kallikrein-kinin system, but not vascular endothelial growth factor, plays a role in the increased vascular permeability associated with ovarian hyperstimulation syndrome.
    Kobayashi H; Okada Y; Asahina T; Gotoh J; Terao T
    J Mol Endocrinol; 1998 Jun; 20(3):363-74. PubMed ID: 9687159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hyperstimulation syndrome: a new insight into an old enigma.
    Orvieto R; Ben-Rafael Z
    J Soc Gynecol Investig; 1998; 5(3):110-3. PubMed ID: 9614638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS
    Stem Cells; 2003; 21(1):118-9. PubMed ID: 12529559
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum vascular endothelial growth factor levels are poorly predictive of subsequent ovarian hyperstimulation syndrome in highly responsive women undergoing assisted conception.
    Mathur R; Hayman G; Bansal A; Jenkins J
    Fertil Steril; 2002 Dec; 78(6):1154-8. PubMed ID: 12477503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.
    McClure N; Healy DL; Rogers PA; Sullivan J; Beaton L; Haning RV; Connolly DT; Robertson DM
    Lancet; 1994 Jul; 344(8917):235-6. PubMed ID: 7913160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of VEGF levels for ovarian hyperstimulation.
    Bussen S; Dietl J
    Fertil Steril; 2003 Sep; 80(3):681-2; author reply 682. PubMed ID: 12969739
    [No Abstract]   [Full Text] [Related]  

  • 13. [Vascular endothelial growth factor and nitric oxide].
    Liu YQ; Zhou AR
    Sheng Li Ke Xue Jin Zhan; 2000 Jan; 31(1):69-71. PubMed ID: 12532773
    [No Abstract]   [Full Text] [Related]  

  • 14. The possible role of the immune system in the aetiopathogenesis of ovarian hyperstimulation syndrome.
    Mathur RS; Jenkins JM; Bansal AS
    Hum Reprod; 1997 Dec; 12(12):2629-34. PubMed ID: 9455826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular perspective: VEGF and angiogenesis.
    Goodsell DS
    Oncologist; 2002; 7(6):569-70. PubMed ID: 12490744
    [No Abstract]   [Full Text] [Related]  

  • 16. Involvement of G proteins in vascular permeability factor/vascular endothelial growth factor signaling.
    Mukhopadhyay D; Zeng H
    Cold Spring Harb Symp Quant Biol; 2002; 67():275-83. PubMed ID: 12858550
    [No Abstract]   [Full Text] [Related]  

  • 17. Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.
    Zachary I
    IDrugs; 2003 Mar; 6(3):224-31. PubMed ID: 12789611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular endothelial growth factor--fundamental research and experimental study in plastic surgery].
    Huang CY; Shen ZY
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2002 Jan; 16(1):64-9. PubMed ID: 11826659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma, apoptosis, and growth factors.
    Beierle EA; Dai W; Langham MR; Chen MK
    Am Surg; 2003 Jan; 69(1):28-31. PubMed ID: 12575776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood vessels and nerves: together or not?
    Hogg PJ; McLachlan EM
    Lancet; 2002 Nov; 360(9347):1714. PubMed ID: 12480422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.